Pharma R&D Today
Ideas and Insight supporting all stages of Drug Discovery & Development
Posted on February 18th, 2016 by Thibault GeouiPharma R&D
In the last three decades, the pharmaceutical industry has undergone a transformation unprecedented in the nearly 100-year history of prescription drugs. (more…)
Posted on February 10th, 2016 by Betsy DavisPharma R&D
I like to think of scientific discovery as not unlike parenthood: scientists create a piece of knowledge (like a child), and then release it to its own life in the world (a grown-up child), and, often, that piece of knowledge informs the (more…)
Posted on February 9th, 2016 by Christy J. WilsonPharma R&D
Last month’s announcement that industry giants AstraZeneca, GSK, and Johnson & Johnson had teamed up with three well-regarded UK universities –Imperial College London, University College London, and University of (more…)
Posted on February 8th, 2016 by Joanna AldredChemistry
How sensitive are you to pain? Many women feel that men are more sensitive to pain (or at least make more fuss about it). They often cite childbirth as one of the many reasons females are so much tougher than males. (more…)
Posted on January 26th, 2016 by Betsy DavisPharma R&D
My favorite quote about why drug discovery, despite very productive decades of productivity and innovation, has seemed to have reached the drought is from Ashutosh Jogalekar in Scientific American blog: (more…)
About this Blog
The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.
Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier, its affiliates and sponsors or its parent company, Reed Elsevier.